Creatinine News and Research

RSS

PMDA approves use of LYNPARZA in patients with BRCA-mutated breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that Japan's Pharmaceuticals and Medical Devices Agency has approved LYNPARZA tablets for use in patients with unresectable or recurrent BRCA-mutated, human epidermal growth factor receptor 2 -negative breast cancer who have received prior chemotherapy.

2 Jul 2018

Study shows improvements in adherence, outcomes of gout patients receiving text message reminders

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate significant improvements in adherence and clinical outcomes in gout patients who received a daily text message to remind them to take allopurinol.

14 Jun 2018

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Bristol-Myers Squibb Company today announced patient-reported outcomes data from the Phase 3 CheckMate -214 trial in intermediate- and poor-risk patients with advanced renal cell carcinoma treated with the Immuno-Oncology combination Opdivo plus low-dose Yervoy versus sunitinib over a two-year follow-up period.

1 Jun 2018

Higher protein intake helps heart failure patients to live longer, shows study

Heart failure patients who consume more protein live longer, according to research presented today at Heart Failure 2018 and the World Congress on Acute Heart Failure, a European Society of Cardiology congress.

28 May 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

Women with gestational diabetes may be at greater risk for chronic kidney disease

Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears in Diabetes Care.

21 May 2018

Siemens Healthineers and Hill-Rom join to provide comprehensive solutions for primary diabetes care

Siemens Healthineers and Hill-Rom signed a co-marketing agreement to provide a suite of point-of-care diagnostic instruments that, for the first time, enable primary healthcare providers in the U.S. to bridge gaps in diabetes care and satisfy value-based quality measures in a single office visit.

From Siemens Healthineers Point of Care Diagnostics 16 May 2018

Analysis reveals decreasing trend in infection-related mortality among kidney transplant recipients

Since the 1990s, the risk of dying from infections after kidney transplantation has dropped by half, according to a recent analysis. The analysis, which appears in an upcoming issue of the Clinical Journal of the American Society of Nephrology, also found that common bacterial infections remain the most frequent cause of infection-related death among transplant recipients.

6 Apr 2018

Research highlights methods to identify antibiotic related kidney damage in children with CF

New research, published in Nature Scientific Reports, conducted by the University and partners highlights effective methods for identifying a common side effect in children receiving drug treatments for Cystic fibrosis.

28 Mar 2018

Study finds first evidence of delayed aging among Americans

Americans may be aging more slowly than they were two decades ago. A new study by University of Southern California and Yale University researchers suggests that at least part of the gains in life expectancy over recent decades may be due to a change in the rate of biological aging, rather than simply keeping ailing people alive.

16 Mar 2018

Many patients show CKD signs prior to diabetes diagnosis

Many patients who will later be diagnosed with diabetes show signs of chronic kidney disease (CKD) even before their diabetes diagnosis, according to a study by researchers with the University of Tennessee Health Science Center and VA MidSouth Healthcare Network.

14 Mar 2018

Research identifies new biomarkers for future dementia risk

Sudha Seshadri, M.D., founding director of the Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases at UT Health San Antonio, is co-leader and senior author on research announced March 6 that identifies novel biomarkers of risk for future dementia.

6 Mar 2018

Study finds no association between current or previous marijuana use and kidney function

New study of nearly 14,000 individuals finds reassuring lack of evidence of the effect of infrequent, relatively light use of marijuana on kidney function, reports The American Journal of Medicine

1 Mar 2018

Black patients found to be underrepresented in prostate cancer clinical trials

Clinical trials can offer patients access to cutting-edge treatments with the potential to extend their survival and shape the standard of care in the future.

8 Feb 2018

Early and targeted treatment of dnDSA preserves allograft function

Development of de novo donor-specific antibodies (dnDSA) is known to cause graft failure. Therefore, a protocol aimed at prospective monitoring and treating dnDSA--before it can cause graft damage--was developed for kidney transplant recipients at Children National Health System.

5 Feb 2018

Researchers turn to new biomarkers for predicting organ transplant rejection

Organ transplants save lives, but the story doesn't end when a patient emerges from the operating room. Rejection episodes, in which the immune system rallies against the new organ, can occur.

31 Jan 2018

U.S. FDA approves first drug for patients with germline BRCA-mutated metastatic breast cancer

AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.

12 Jan 2018